Rationale and protocol design for the TORG1835/NEXT-SHIP...

Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of carboplatin, etoposide and nintedanib for unresectable limited/extensive disease small cell lung cancer with idiopathic pulmonary fibrosis

Ikeda, Satoshi, Ogura, Takashi, Kato, Terufumi, Kenmotsu, Hirotsugu, Iwasawa, Tae, Misumi, Toshihiro, Yamanaka, Takeharu, Okamoto, Hiroaki
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Journal:
Therapeutic Advances in Medical Oncology
DOI:
10.1177/1758835920923431
Date:
January, 2020
File:
PDF, 222 KB
2020
Conversion to is in progress
Conversion to is failed